Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

被引：0
|
作者：
Goki Suda
Mineo Kudo
Atsushi Nagasaka
Ken Furuya
Yoshiya Yamamoto
Tomoe Kobayashi
Keisuke Shinada
Miki Tateyama
Jun Konno
Yoko Tsukuda
Kazushi Yamasaki
Megumi Kimura
Machiko Umemura
Takaaki Izumi
Seiji Tsunematsu
Fumiyuki Sato
Katsumi Terashita
Masato Nakai
Hiromasa Horimoto
Takuya Sho
Mitsuteru Natsuizaka
Kenichi Morikawa
Koji Ogawa
Naoya Sakamoto
机构：
[1] Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Hokkaido University,undefined
[3] Sapporo Hokuyu Hospital,undefined
[4] Sapporo City General Hospital,undefined
[5] JCHO Hokkaido Hospital,undefined
[6] Hakodate City Hospital,undefined
[7] Tomakomai City Hospital,undefined
[8] Keiwakai Ebetsu Hospital,undefined
[9] Tomakomai Nissho Hospital,undefined
[10] Hakodate Central General Hospital,undefined
来源：
Journal of Gastroenterology | 2016年 / 51卷
关键词：
HCV; Hemodialysis; Daclatasvir; Asunaprevir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 740
页数：7
相关论文
共 50 条
  • [31] Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis (vol 51, pg 741, 2016)
    Toyoda, Hidenori
    Kumada, Takashi
    Tada, Toshifumi
    Takaguchi, Koichi
    Ishikawa, Toru
    Tsuji, Kunihiko
    Zeniya, Mikio
    Iio, Etsuko
    Tanaka, Yasuhito
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (07) : 750 - 750
  • [32] Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C
    Klimova, E. A.
    Burnevich, E. Z.
    Chulanov, V. P.
    Gusev, D. A.
    Znoyko, O. O.
    Batskikh, S. N.
    Kizlo, S. N.
    Mamonova, N. A.
    Tarkhova, E. P.
    Krasavina, E. N.
    Samsonov, M. Yu
    Yushchuk, N. D.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (08) : 67 - 74
  • [33] ASUNAPREVIR PLUS DACLATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
    Zeuli, J. D.
    Adie, S. K.
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2015, 51 (11) : 629 - 643
  • [34] Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan
    Suzuki, Fumitaka
    Hatanaka, Naoya
    Bando, Etsuya
    Nakamura, Koji
    Komoto, Akira
    HEPATOLOGY INTERNATIONAL, 2018, 12 (03) : 244 - 253
  • [35] Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan
    Fumitaka Suzuki
    Naoya Hatanaka
    Etsuya Bando
    Koji Nakamura
    Akira Komoto
    Hepatology International, 2018, 12 : 244 - 253
  • [36] Severe Hepatotoxicity Associated With Asunaprevir and Daclatasvir in Chronic Hepatitis C REPLY
    Fujii, Yohei
    Uchida, Yoshihito
    Mochida, Satoshi
    HEPATOLOGY, 2016, 63 (06) : 2064 - 2065
  • [37] The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir plus asunaprevir
    Hayes, C. Nelson
    Imamura, Michio
    Chayama, Kazuaki
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (02) : 103 - 113
  • [38] Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment
    Suda, Goki
    Nagasaka, Atsushi
    Yamamoto, Yoshiya
    Furuya, Ken
    Kumagai, Kenichi
    Kudo, Mineo
    Terashita, Katsumi
    Kobayashi, Tomoe
    Tsunematsu, Izumi
    Yoshida, Junichi
    Meguro, Takashi
    Kimura, Megumi
    Ito, Jun
    Umemura, Machiko
    Izumi, Takaaki
    Tsunematsu, Seiji
    Sato, Fumiyuki
    Tsukuda, Yoko
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1127 - 1136
  • [39] Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Takaguchi, Koichi
    Toyoda, Hidenori
    Tsutsui, Akemi
    Suzuki, Yoshiyuki
    Nakamuta, Makoto
    Imamura, Michio
    Senoh, Tomonori
    Nagano, Takuya
    Tada, Toshifumi
    Tachi, Yoshihiko
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Shibata, Hiroshi
    Joko, Kouji
    Okubo, Hironao
    Tsuji, Kunihiko
    Takaki, Shintaro
    Watanabe, Tsunamasa
    Ogawa, Chikara
    Chayama, Kazuaki
    Kumada, Takashi
    Kudo, Masatoshi
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (08) : 742 - 751
  • [40] Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Koichi Takaguchi
    Hidenori Toyoda
    Akemi Tsutsui
    Yoshiyuki Suzuki
    Makoto Nakamuta
    Michio Imamura
    Tomonori Senoh
    Takuya Nagano
    Toshifumi Tada
    Yoshihiko Tachi
    Atsushi Hiraoka
    Kojiro Michitaka
    Hiroshi Shibata
    Kouji Joko
    Hironao Okubo
    Kunihiko Tsuji
    Shintaro Takaki
    Tsunamasa Watanabe
    Chikara Ogawa
    Kazuaki Chayama
    Takashi Kumada
    Masatoshi Kudo
    Hiromitsu Kumada
    Journal of Gastroenterology, 2019, 54 : 742 - 751
12345